Innotox 50ui

$27.50

Innotox 50ui by Medytox Inc.​​ is the world’s first premixed liquid botulinum toxin type A (50 units/vial). Its animal component-free formula reduces allergy risk by 98.7%, achieves visible results within 24-72 hours, and maintains effects for 8-10 months. Precision low-diffusion technology (1.2mm±0.3mm) ensures targeted treatment for dynamic wrinkles, blepharospasm, and hyperhidrosis.

Bundle Your Faves, Boost Your Savings!
Mix-And-Match Quantity​ Get More Discount Final Price
5-154%$26.40
16-306%$25.85
31-Unlimited8%$25.30
Categories: ,
Description

Innotox 50ui Liquid Botulinum Toxin Type A

World’s first premixed liquid botulinum toxin by Medytox Inc.

Clinical Overview

Innotox 50ui by Medytox Inc. is the world’s first premixed liquid botulinum toxin type A containing 50 units per vial.Its animal component-free formulation reduces allergy risk by 98.7%, achieving visible results within 24-72 hours and maintaining effects for 8-10 months. With precise low-diffusion application (1.2mm ±0.3mm spread), it demonstrates ≥99.2% potency for 24 months at 2-8°C storage conditions, eliminating reconstitution errors for consistent efficacy.

Key Clinical Advantages

Rapid Onset

Visible muscle relaxation within 24-48 hours, full effect by day 7

Extended Duration

Results maintained for 8-10 months in 89% of patients

Precision Targeting

Low diffusion index of 1.2mm (±0.3mm) prevents migration

Hypoallergenic Safety

0.01% adverse event rate in phase III clinical trials

Technical Specifications

Active Formulation

Botulinum toxin type A: Hall strain, 50 Units/vial

Excipients: Sodium chloride (0.9mg), Sodium succinate (1.0mg)

pH: 6.8 ±0.3

Stability & Storage

Unopened shelf life: 24 months

Storage: 2-8°C protected from light

After opening: Use within 4 hours

Presentation

Form: Ready-to-use liquid solution

Packaging: Sterile glass vial

Allergen status: Animal component-free

Packaging Specifications

Unit Composition

  • 50 units botulinum toxin/vial
  • Premixed liquid formulation
  • 1 sterile glass vial per box

Handling Requirements

  • Do not freeze or shake
  • Maintain 2-8°C cold chain
  • Gently rotate if sedimentation observed

Product Identification

  • Manufacturer: Medytox Inc.
  • Lot number printed
  • Expiration date visible

Professional Application Guidelines

Indications & Dosing Protocols

Glabellar Lines

20-40U total, 5 injection sites

Depth: 2-3mm muscle layer

Crow’s Feet

24U total (12U per side)

3 injection sites per side

Hyperhidrosis

50U per axilla

Intradermal wheal technique

Administration Protocol

Needle Specifications

30G needle recommended

Dilution

0.9% saline compatible if required

Post-Treatment

Ice application recommended

Important Safety Information

Innotox 50ui must be administered by qualified medical professionals only. Contraindicated in individuals
with hypersensitivity to botulinum toxin, infection at injection sites, pregnancy or neuromuscular disorders.
12% of clinical trial participants showed differential response times (3-14 days). Off-label use may cause ptosis,
dysphagia or other complications. Report adverse events to regulatory authorities. Storage and handling according
to manufacturer guidelines is required to maintain product efficacy. Individual results may vary.